Ni sulphate is generally bringing a 35% premium and should be listed separately on the LME by mid year. This *should* mean MCR would be profitable if they were to recommence Ni operations.
Ann: Share Purchase Plan closes heavily oversubscribed, page-22
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
